Experts are preparing a dialysis machine for use in critically ill patients in hospital intensive care units. Ardelyx and ...

Nestled between J P Morgan’s London headquarters and the Mastercard office in Canary Wharf, London, is an unassuming building ...

The UK MHRA has approved Pierre Fabre’s vibegron for the treatment of overactive bladder (OAB) syndrome in adult patients.

Bayer’s Nubeqa is approved by the US FDA as a treatment for metastatic castration-resistant prostate cancer (mCRPC) and ...

The FDA’s rare disease innovation hub aims to streamline rare disease drug development. Credit: PeopleImages.com – Yuri A via ...

For the first half of 2024, Novartis reported net income of $5.9bn and net sales of $24.3bn. Credit: JHVEPhoto/Shutterstock.

Gene therapy trials can often be held back by cost and complexity. New database software is helping optimise the process.

AbbVie has maintained a strong position within the immunology space for the past few years, largely due to the success of its ...

The funding will aid CytoReason to expand disease models and proprietary data. Credit: PeopleImages.com – Yuri A / ...

Biomanufacturers must tread carefully when seeking the optimum solution for their drug product's commercial supply chain.

In January, the US House Select Committee on the Strategic Competition between the US and the Chinese Communist Party ...

The funds will finance late-stage trials of CRD-750, a PDE9 inhibitor for heart failure, and CRD-4730, a CaMKII inhibitor.